rap chart, page-3812

"there are too many upcoming Ann's that could send this back to 20c very quickly" - Seriously? What? All of the re-rate pins we had our hopes on have either been delivered without producing a re-rate, or have lapsed. ResappDx CE Mark: delivered. Sleep Apnea app: delivered. ResappDx TGA approval: delivered. ResappDx FDA approval: parked.

The only news we're waiting on that might shift the share price significantly is how successful the commercialisation venture is going, and that won't come until the end of October with the next quarterly report.

So my suggestion is that if you align your expectations with reality then you'll be far less frustrated.